Cargando…
NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors
Purpose. European Mistletoe (Viscum album L.) extracts (mistletoe) are commonly used for cancer treatment in Europe. This phase I study of gemcitabine (GEM) and mistletoe in advanced solid cancers (ASC) evaluated: (1) safety, toxicity, and maximum tolerated dose (MTD), (2) absolute neutrophil count...
Autores principales: | Mansky, Patrick J., Wallerstedt, Dawn B., Sannes, Timothy S., Stagl, Jamie, Johnson, Laura Lee, Blackman, Marc R., Grem, Jean L., Swain, Sandra M., Monahan, Brian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826324/ https://www.ncbi.nlm.nih.gov/pubmed/24285980 http://dx.doi.org/10.1155/2013/964592 |
Ejemplares similares
-
Erratum to “NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors”
por: Mansky, Patrick J., et al.
Publicado: (2014) -
Difficulties and Perspectives of Immunomodulatory Therapy with Mistletoe Lectins and Standardized Mistletoe Extracts in Evidence-Based Medicine
por: Hajtó, Tibor, et al.
Publicado: (2011) -
Mistletoe as an Oxytoxic
Publicado: (1878) -
The Mistletoe Bough
Publicado: (1871) -
Mistletoe as an Anti-Hemorrhagic
Publicado: (1881)